Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Top Cited Papers
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 33 (4), 207-214
- https://doi.org/10.1016/j.tips.2012.01.005
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1Cell, 2011
- Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferaseCancer Chemotherapy and Pharmacology, 2010
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason GradingCancer Cell, 2010
- Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1αCancer Chemotherapy and Pharmacology, 2010
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- HIF-Dependent Antitumorigenic Effect of Antioxidants In VivoCancer Cell, 2007
- Metastasis and stem cell pathwaysCancer and Metastasis Reviews, 2007
- RACK1 Competes with HSP90 for Binding to HIF-1α and Is Required for O2-Independent and HSP90 Inhibitor-Induced Degradation of HIF-1αMolecular Cell, 2007